Jonathan Colasanti

1.7k citations

69 papers · 897 indexed · h-index 15

Impact in

Virology top 5%
- HIV Research and Treatment
Infectious Diseases top 2%
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment

Papers in ⓘ

Virology 13
- HIV Research and Treatment 10
Infectious Diseases 49
- HIV/AIDS Research and Interventions 47
- HIV/AIDS drug development and treatment 12

Co-authors: Wendy S. Armstrong (24 shared papers)Carlos del Rı́o (24 shared papers)Allison L. Agwu (4 shared papers)Mamta K. Jain (3 shared papers)Michael A. Horberg (4 shared papers)Melanie Thompson (2 shared papers)Tulika Singh (2 shared papers)William R. Short (2 shared papers)
Journals: Open Forum Infectious Diseases (16 papers)Clinical Infectious Diseases (11 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (5 papers)AIDS Care (5 papers)Journal of the International Association of Providers of AIDS Care (JIAPAC) (3 papers)
Partner nations: United States Canada Nigeria

In The Last Decade

Jonathan Colasanti

63 papers receiving 881 citations

Peers

Countries citing papers authored by Jonathan Colasanti

Since Specialization

Citations

This map shows the geographic impact of Jonathan Colasanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Colasanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Colasanti more than expected).

Fields of papers citing papers by Jonathan Colasanti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Colasanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Colasanti. The network helps show where Jonathan Colasanti may publish in the future.

Co-authors

The 25 scholars most cited alongside Jonathan Colasanti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jonathan Colasanti Line = papers co-authored together Jonathan Colasanti links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America Clinical Infectious Diseases ·Melanie Thompson, Michael A. Horberg, Allison L. Agwu, Jonathan Colasanti, Mamta K. Jain, William R. Short, Tulika Singh, Judith A. Aberg	2020	130
2	Continuous Retention and Viral Suppression Provide Further Insights Into the HIV Care Continuum Compared to the Cross-sectional HIV Care Cascade Clinical Infectious Diseases ·Jonathan Colasanti, Jane Kelly, Eugene Pennisi, Yi‐Juan Hu, Christin Root, Denise Hughes, Carlos del Rı́o, Wendy S. Armstrong	2015	100
3	Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States Open Forum Infectious Diseases ·Jonathan Colasanti, Jeri Sumitani, C. Christina Mehta, Yiran Zhang, Minh Ly Nguyen, Carlos del Rı́o, Wendy S. Armstrong	2018	73
4	An Exploratory Study to Assess Individual and Structural Level Barriers Associated With Poor Retention and Re-engagement in Care Among Persons Living With HIV/AIDS JAIDS Journal of Acquired Immune Deficiency Syndromes ·Jonathan Colasanti, Natalie Stahl, Eugene W. Farber, Carlos del Rı́o, Wendy S. Armstrong	2017	58
5	Innovations in Human Immunodeficiency Virus (HIV) Care Delivery During the Coronavirus Disease 2019 (COVID-19) Pandemic: Policies to Strengthen the Ending the Epidemic Initiative—A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association Clinical Infectious Diseases ·Wendy S. Armstrong, Allison L. Agwu, Ernie-Paul Barrette, Rachel Bender Ignacio, Jennifer Chang, Jonathan Colasanti, Michelle Floris-Moore, Marwan Haddad, Lynsay MacLaren, Andrea Weddle	2020	45
6	Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South Open Forum Infectious Diseases ·Lauren F. Collins, Della Corbin-Johnson, Meron Asrat, Zoey P Morton, Kaylin V. Dance, Alton Condra, Kimberly Jenkins, Marie Todd-Turner, Jeri Sumitani, Bradley L. Smith, Wendy S. Armstrong, Jonathan Colasanti	2022	44
7	Clinical characteristics, comorbidities and outcomes among persons with HIV hospitalized with coronavirus disease 2019 in Atlanta, Georgia AIDS ·Lauren F. Collins, Caitlin A. Moran, Nora Oliver, Abeer Moanna, Cecile D. Lahiri, Jonathan Colasanti, Colleen F. Kelley, Minh Ly Nguyen, Vincent C. Marconi, Wendy S. Armstrong, Ighovwerha Ofotokun, Anandi N. Sheth	2020	27
8	Challenges of reaching 90–90–90 in the Southern United States Current Opinion in HIV and AIDS ·Jonathan Colasanti, Wendy S. Armstrong	2019	23
9	Primary Care Guidance for Providers Who Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America Clinical Infectious Diseases ·Michael A. Horberg, Melanie Thompson, Allison L. Agwu, Jonathan Colasanti, Marwan Haddad, Mamta K. Jain, Grace A. McComsey, Asa Radix, Natella Rakhmanina, William R. Short, Tulika Singh, Hansel Tookes	2024	22
10	Chronic Opioid Therapy in People Living With Human Immunodeficiency Virus: Patients’ Perspectives on Risks, Monitoring, and Guidelines Clinical Infectious Diseases ·Jonathan Colasanti, Marlene C. Lira, Debbie M. Cheng, Jane M. Liebschutz, Judith I. Tsui, Leah S. Forman, Meg Sullivan, Alexander Y. Walley, Carly Bridden, Christin Root, Melissa C. Podolsky, Catherine Abrams, Kishna Outlaw, Catherine E. Harris, Wendy S. Armstrong, Jeffrey H. Samet, Carlos del Rı́o	2018	21
11	Study protocol for the targeting effective analgesia in clinics for HIV (TEACH) study – a cluster randomized controlled trial and parallel cohort to increase guideline concordant care for long-term opioid therapy among people living with HIV SHILAP Revista de lepidopterología ·Marlene C. Lira, Judith I. Tsui, Jane M. Liebschutz, Jonathan Colasanti, Christin Root, Debbie M. Cheng, Alexander Y. Walley, Meg Sullivan, Christopher W. Shanahan, Kristen O’Connor, Catherine Abrams, Leah S. Forman, Christine E. Chaisson, Carly Bridden, Melissa C. Podolsky, Kishna Outlaw, Catherine E. Harris, Wendy S. Armstrong, Carlos del Rı́o, Jeffrey H. Samet	2019	19
12	Improving the Delivery of Chronic Opioid Therapy Among People Living With Human Immunodeficiency Virus: A Cluster Randomized Clinical Trial Clinical Infectious Diseases ·Jeffrey H. Samet, Judith I. Tsui, Debbie M. Cheng, Jane M. Liebschutz, Marlene C. Lira, Alexander Y. Walley, Jonathan Colasanti, Leah S. Forman, Christin Root, Christopher W. Shanahan, Margaret M. Sullivan, Carly Bridden, Catherine Abrams, Catherine E. Harris, Kishna Outlaw, Wendy S. Armstrong, Carlos del Rı́o	2020	19
13	Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder AIDS Research and Human Retroviruses ·Nathan A. Summers, Jonathan Colasanti, Daniel J. Feaster, Wendy S. Armstrong, Allan Rodríguez, Mamta K. Jain, Petra Jacobs, Lisa R. Metsch, Carlos del Rı́o	2020	16
14	The COVID-19 pandemic as a catalyst for differentiated care models to end the HIV epidemic in the United States: applying lessons from high-burden settings AIDS ·Lauren F. Collins, Jonathan Colasanti, Minh Ly Nguyen, Caitlin A. Moran, Cecile D. Lahiri, Vincent C. Marconi, Wendy S. Armstrong, N. Sarita Shah	2020	16
15	R5 Human Immunodeficiency Virus Type 1 Infection of Fetal Thymic Organ Culture Induces Cytokine and CCR5 Expression Journal of Virology ·Shailesh K. Choudhary, Neelima Choudhary, Kyleigh Kimbrell, Jonathan Colasanti, Argyrios Ziogas, David Kwa, Hanneke Schuitemaker, David Camerini	2004	15
16	Mental Health Service Utilization Among Young Black Gay, Bisexual, and Other Men Who Have Sex with Men in HIV Care: A Retrospective Cohort Study AIDS Patient Care and STDs ·Sophia A. Hussen, Daniel M. Camp, Sarah B. Wondmeneh, Kamini Doraivelu, Nancy Holbrook, Shamia J. Moore, Jonathan Colasanti, Mohammed K. Ali, Eugene W. Farber	2020	13
17	Identifying Implementation Determinants and Strategies for Long-Acting Injectable Cabotegravir–Rilpivirine in People With HIV Who Are Virally Unsuppressed JAIDS Journal of Acquired Immune Deficiency Syndromes ·Matthew D. Hickey, Janet Grochowski, Francis Mayorga‐Munoz, Jon Oskarsson, Elizabeth Imbert, Matthew A. Spinelli, John D. Szumowski, Ayesha Appa, Kimberly A. Koester, Emily Dauria, Moira McNulty, Jonathan Colasanti, Diane V. Havlir, Monica Gandhi, Katerina Christopoulos	2024	13
18	Provider opioid prescribing practices and the belief that opioids keep people living with HIV engaged in care: a cross-sectional study AIDS Care ·Judith I. Tsui, Alexander Y. Walley, Debbie M. Cheng, Marlene C. Lira, Jane M. Liebschutz, Leah S. Forman, Margaret M. Sullivan, Jonathan Colasanti, Christin Root, Kristen O’Connor, Christopher W. Shanahan, Carly Bridden, Carlos del Rı́o, Jeffrey H. Samet	2019	13
19	Predictors of pain-related functional impairment among people living with HIV on long-term opioid therapy AIDS Care ·David P. Serota, Christine Capozzi, Sara Lodi, Jonathan Colasanti, Leah S. Forman, Judith I. Tsui, Alexander Y. Walley, Marlene C. Lira, Jeffrey H. Samet, Carlos del Rı́o, Jessica S. Merlin	2020	13
20	Charting the Path Forward: Development, Goals and Initiatives of the 2019 Infectious Diseases Society of America Strategic Plan Clinical Infectious Diseases ·Cynthia L. Sears, Thomas M. File, Barbara D. Alexander, Daniel P. McQuillen, Ann Macintyre, Upton Allen, Jonathan Colasanti, Javeed Siddiqui, Kelly R. Reveles, Chris Busky, (unknown)	2019	13

About Jonathan Colasanti

Jonathan Colasanti is a scholar working on Virology, Infectious Diseases, Epidemiology, Anesthesiology and Pain Medicine and Pediatrics, Perinatology and Child Health, having authored 69 papers that have together received 897 indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (47 papers), HIV, Drug Use, Sexual Risk (37 papers), Opioid Use Disorder Treatment (16 papers), HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers), Pharmacological Effects and Toxicity Studies (6 papers), Prenatal Substance Exposure Effects (6 papers) and Sex work and related issues (6 papers). The work is most often cited by research in Virology (198 citations), Infectious Diseases (614 citations), Epidemiology (475 citations), Emergency Medicine (115 citations) and General Health Professions (195 citations). Jonathan Colasanti has collaborated with scholars based in United States, Canada and Nigeria. Frequent co-authors include Wendy S. Armstrong, Carlos del Rı́o, Allison L. Agwu, Mamta K. Jain, Michael A. Horberg, Melanie Thompson, Tulika Singh, William R. Short, Judith A. Aberg and Minh Ly Nguyen. Their work appears in journals such as Open Forum Infectious Diseases, Clinical Infectious Diseases, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS Care and Journal of the International Association of Providers of AIDS Care (JIAPAC).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact